K286-4209 Screening compound: 5-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-3-(2-methylphenyl)-6-phenyl-2-sulfanylidene-2H,3H,6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one

K286-4209 Screening compound: 5-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-3-(2-methylphenyl)-6-phenyl-2-sulfanylidene-2H,3H,6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one
K286-4209 Screening compound: 5-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-3-(2-methylphenyl)-6-phenyl-2-sulfanylidene-2H,3H,6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one alternative view

Chemical Structure Depiction of ChemDiv screening compound K286-4209
5-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-3-(2-methylphenyl)-6-phenyl-2-sulfanylidene-2H,3H,6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K286-4209

Molecular Formula

C28H19N3O4S3 (C28 H19 N3 O4 S3)

Compound Name

5-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-3-(2-methylphenyl)-6-phenyl-2-sulfanylidene-2H,3H,6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one

IUPAC name

5-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-3-(2-methylphenyl)-6-phenyl-2-sulfanylidene-2H3H6H7H-[13]thiazolo[45-d]pyrimidin-7-one

SMILES

Cc(cccc1)c1N(C(N=C(N(c1ccccc1)C1=O)SCC(c(ccc(O)c2)c2O2)=CC2=O)=C1S1)C1=S

InChI

InChI=1S/C28H19N3O4S3/c1-16-7-5-6-10-21(16)31-25-24(38-28(31)36)26(34)30(18-8-3-2-4-9-18)27(29-25)37-15-17-13-23(33)35-22-14-19(32)11-12-20(17)22/h2-14,32H,15H2,1H3

InChI Key

ZBHJTKJUFJQHDO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15091033

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

557.67

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.047

Distribution Coefficient, logD

5.018

Water Solubility, LogSw

-4.49

Polar Surface Area

64.678

Acid Dissociation Constant (pKa)

8.56

Base Dissociation Constant (pKb)

0.98

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

7.10

K286-4209 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

C-Met Library (15277 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
Targets:
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with K286-4209 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K286-4209?
Check Price and Availability of K286-4209, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K286-4209 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K286-4209
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K286-4209
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K286-4209 available by request